Pharmacology, Toxicology and Pharmaceutical Science
Haplorhini
100%
Levodopa
100%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
100%
AMPA Receptor
100%
Levodopa-Induced Dyskinesia
100%
Mitochondrial Permeability Transition Pore
100%
Talampanel
42%
Alpha Amino 3 Hydroxy 5 Methyl 4 Isoxazolepropionic Acid
42%
6 Quinoxalinecarboxylic Acid Piperidide
28%
Glutamate Receptor
28%
Dyskinesia
28%
N Methyl Dextro Aspartic Acid
14%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
14%
Antiparkinson Agent
14%
AMPA Receptor Antagonist
14%
Monotherapy
14%
Isoxazole
14%
Keyphrases
AMPA Receptor (AMPAR)
100%
Levodopa
100%
Levodopa-induced Dyskinesia
100%
Receptor Blockade
100%
MPTP Monkey
100%
High Dose
28%
Dyskinesia
28%
Motor Activity
28%
Non-competitive
28%
Amino
14%
Monkey
14%
Glutamate Receptors
14%
Methyl
14%
Monotherapy
14%
Parkinsonian
14%
AMPA-type Glutamate Receptor
14%
Parkinsonian Symptoms
14%
Receptor Downregulation
14%
AMPA Receptor Antagonist
14%
Isoxazole
14%
Motor Fluctuations
14%
Anti-Parkinson
14%
NMDA Antagonist
14%
Parkinsonian Signs
14%
AMPA Antagonist
14%
MPTP-lesioned Monkey
14%